| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Phenol, p-chloro-m-trifluoromethyl- |
|
6294-93-5 |
詳細(xì)
|
| Alpha-Estradiol；Epiestradiol;Epiestrol;17α-Estradiol;Alfatradiol |
|
57-91-0 |
詳細(xì)
|
| Indole-3-carbinol；Indole-3-Methanol;I3C;3-Indolemethanol |
|
700-06-1 |
詳細(xì)
|
| Stattic；STAT3 Inhibitor V |
|
19983-44-9 |
詳細(xì)
|
| Dihydrosinapyl alcohol；Dihydrosinapylalcohol |
|
20736-25-8 |
詳細(xì)
|
| (S)-Leucic acid；Hydroxyisocaproic acid;L-LEUCIC ACID;(S)-(?)-2-Hydroxyisocaproic acid |
|
13748-90-8 |
詳細(xì)
|
| Glycocyamine；2-Guanidinoacetic acid;Guanidoacetic acid |
|
352-97-6 |
詳細(xì)
|
| d-Isothujone |
|
471-15-8 |
詳細(xì)
|
| Aldioxa；RC 172;RC-172 |
|
5579-81-7 |
詳細(xì)
|
| Astragaloside I；Cyclosieversioside B;Astrasieversianin IV |
|
84680-75-1 |
詳細(xì)
|
| D-Valine；H-D-Val-OH;(R)-Valine;Valine, D- |
|
640-68-6 |
詳細(xì)
|
| 11-Deoxyalisol B |
|
155073-73-7 |
詳細(xì)
|
| Lupichromone；5,7-Dihydroxy-6,8-diprenylchromone |
|
162616-72-0 |
詳細(xì)
|
| Isodaphnoretin B |
|
944824-29-7 |
詳細(xì)
|
| Bempedoic acid；ESP-55016;ETC-1002;ETC 1002;ETC1002 |
|
738606-46-7 |
詳細(xì)
|
| Sulfo-Cy3 diacid |
|
146397-17-3 |
詳細(xì)
|
| BMS817378 |
|
1174161-69-3 |
詳細(xì)
|
| Kauran-18-oic acid, 16,17,19-trihydroxy-, (4α)-；(10alpha)-16alpha,17,19-Trihydroxykaurane-18-oic acid |
|
308821-59-2 |
詳細(xì)
|
| Laurycolactone A |
|
85643-76-1 |
詳細(xì)
|
| Kaempferol 3-O-(6''-galloyl)-beta-D-glucopyranoside |
|
56317-05-6 |
詳細(xì)
|
| Kushenol C |
|
99119-73-0 |
詳細(xì)
|
| Methyl 3-O-feruloylquinate |
|
154418-15-2 |
詳細(xì)
|
| Methyl ganoderate H |
|
98665-11-3 |
詳細(xì)
|
| Nothofagin |
|
11023-94-2 |
詳細(xì)
|
| Pallidol |
|
105037-88-5 |
詳細(xì)
|
| Platycoside K |
|
899447-64-4 |
詳細(xì)
|
| Qianhucoumarin E |
|
156041-02-0 |
詳細(xì)
|
| Sanggenol L |
|
329319-20-2 |
詳細(xì)
|
| Disodium succinate；Sodium succinate |
|
150-90-3 |
詳細(xì)
|
| Tos-Gly-Pro-Arg-ANBA-IPA；tos-GPR-ANBA-IPA |
|
99700-50-2 |
詳細(xì)
|
| Epmedin C；Epimedin C;Baohuoside-VI |
|
110642-44-9 |
詳細(xì)
|
| HCGRP-(8-37)；Human α-CGRP (8-37) |
|
119911-68-1 |
詳細(xì)
|
| Itacitinib；INCB39110;INCB039110 |
|
1334298-90-6 |
詳細(xì)
|
| N-Benzyllinoleamide；(9Z,12Z)-N-Benzyloctadeca-9,12-dienamide |
|
18286-71-0 |
詳細(xì)
|
| Cimifugin 4'-O-β-D-glucopyranoside；Cimifugin 4'-O-beta-D-glucopyranoside |
|
1632110-81-6 |
詳細(xì)
|
| YK11 |
|
1370003-76-1 |
詳細(xì)
|
| LM-1685；LM1685;LM 1685 |
|
416901-58-1 |
詳細(xì)
|
| SGC707 |
|
1687736-54-4 |
詳細(xì)
|
| Trabodenoson；INNO-8875;PJ-875;INNO 8875;PJ 875;PJ875;INNO8875 |
|
871108-05-3 |
詳細(xì)
|
| OTS514 |
|
1338540-63-8 |
詳細(xì)
|
| Hymexelsin |
|
117842-09-8 |
詳細(xì)
|
| NCT-501；NCT501;NCT 501 |
|
1802088-50-1 |
詳細(xì)
|
| Resiniferatoxin；RTX |
|
57444-62-9 |
詳細(xì)
|
| Oxyresveratrol 2-O-β-D-glucopyranoside；Oxyresveratrol 2-O-beta-D-glucopyranoside |
|
392274-22-5 |
詳細(xì)
|
| Urolithin C |
|
165393-06-6 |
詳細(xì)
|
| AZD3264 |
|
1609281-86-8 |
詳細(xì)
|
| N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide；(9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide;Macamide Impurity 14 |
|
883715-23-9 |
詳細(xì)
|
| Isocuparenal |
|
16982-01-7 |
詳細(xì)
|
| Eupahualin C |
|
108525-39-9 |
詳細(xì)
|
| 4,5-Di-O-caffeoylquinic acid methyl ester |
|
188742-80-5 |
詳細(xì)
|
| 2alpha-Hydroxyeupatolide 8-O-angelate |
|
72229-39-1 |
詳細(xì)
|
| voxelotor；GBT 440 |
|
1446321-46-5 |
詳細(xì)
|
| Vedroprevir；GS 9451;GS-9451;GS9451 |
|
1098189-15-1 |
詳細(xì)
|
| PIK-inhibitors；MDK34597 |
|
371934-59-7 |
詳細(xì)
|
| SU5214；SU 5214 |
|
186611-04-1 |
詳細(xì)
|
| PHCCC；(-) PHCCC |
|
179068-02-1 |
詳細(xì)
|
| Guggulsterone；Guggulsterone E&Z |
|
95975-55-6 |
詳細(xì)
|
| Acid yellow 1；Naphthol Yellow;A.F. Yellow No. 1;1307 Yellow;1422 Yellow |
|
846-70-8 |
詳細(xì)
|
| VK-II-86 |
|
955371-84-3 |
詳細(xì)
|
| FIT-039 |
|
1113044-49-7 |
詳細(xì)
|
| ON123300 |
|
1357470-29-1 |
詳細(xì)
|
| Apratoxin A |
|
350791-64-9 |
詳細(xì)
|
| LB100；LB 100;LB-100 |
|
1632032-53-1 |
詳細(xì)
|
| Danirixin；GSK1325756 |
|
954126-98-8 |
詳細(xì)
|
| 4-methyl-6-phenyl-2H-pyranone |
|
4467-30-5 |
詳細(xì)
|
| Ezutromid；SMT C1100;BMN 195;VOX-C1100 |
|
945531-77-1 |
詳細(xì)
|
| 16α-Hydroxytrametenolic acid；16 alpha-Hydroxytrametenolic acid |
|
176390-68-4 |
詳細(xì)
|
| Valbenazine；NBI-98854 |
|
1025504-45-3 |
詳細(xì)
|
| CFI-401870；CFI401870;CFI 401870 |
|
1430741-35-7 |
詳細(xì)
|
| Firsocostat；ND-630;GS-0976;NDI-010976 |
|
1434635-54-7 |
詳細(xì)
|
| BAY1125976 |
|
1402608-02-9 |
詳細(xì)
|
| BAY-876；BAY 876;BAY876 |
|
1799753-84-6 |
詳細(xì)
|
| Visomitin；SKQ1 |
|
934826-68-3 |
詳細(xì)
|
| PF 06260933 dihydrochloride |
|
1883548-86-4 |
詳細(xì)
|
| Relamorelin；BIM-28163;BIM 28163;BIM28131;BIM 28131;BIM-28131;BIM28163 |
|
661472-41-9 |
詳細(xì)
|
| Blarcamesine；AE-37;AVex-73 |
|
195615-83-9 |
詳細(xì)
|
| SRI-011381 hydrochloride；SRI-011381 hydrochloride [1629138-41-5(free base)] |
|
2070014-88-7 |
詳細(xì)
|
| Icerguastat；IFB-088;lcerguastat;Sephin 1 |
|
951441-04-6 |
詳細(xì)
|
| DY268；DY 268;DY-268 |
|
1609564-75-1 |
詳細(xì)
|
| Astin C |
|
148057-23-2 |
詳細(xì)
|
| NOD-IN-1；Compound 4 |
|
132819-92-2 |
詳細(xì)
|
| ML299；VU0463568;ML-299 |
|
1426916-00-8 |
詳細(xì)
|
| TG6-129；TG6 129;TG6129 |
|
1164464-14-5 |
詳細(xì)
|
| GSK6853 |
|
1910124-24-1 |
詳細(xì)
|
| Nidufexor |
|
1773489-72-7 |
詳細(xì)
|
| Avadomide；CC 122 |
|
1015474-32-4 |
詳細(xì)
|
| Jionoside A1 |
|
120444-60-2 |
詳細(xì)
|
| Periplocoside M |
|
116782-73-1 |
詳細(xì)
|
| Carnosine nitrate；(+)-Carnosine nitrate |
|
5852-98-2 |
詳細(xì)
|
| GDC-0326；GDC 0326;GDC0326 |
|
1282514-88-8 |
詳細(xì)
|
| U-0521；U0521;U 0521 |
|
5466-89-7 |
詳細(xì)
|
| Usistapide；R-256918;R 256918;JNJ 16269110;JNJ16269110;JNJ-16269110;R256918 |
|
403989-79-7 |
詳細(xì)
|
| AZD9496 |
|
1639042-08-2 |
詳細(xì)
|
| IDO-IN-1 |
|
914638-30-5 |
詳細(xì)
|
| 7-Angeloylretronecine |
|
6029-82-9 |
詳細(xì)
|
| 6alpha-Hydroxypolyporenic acid C |
|
24513-63-1 |
詳細(xì)
|
| 3-Oxosapriparaquinone |
|
119139-56-9 |
詳細(xì)
|
| 3-O-cis-p-Coumaroylmaslinic acid |
|
69297-40-1 |
詳細(xì)
|
| IGF-I (30-41)；Insulin-like Growth Factor I (30-41);IGF-I 30-41 |
|
82177-09-1 |
詳細(xì)
|
| Oleyl myristate |
|
22393-93-7 |
詳細(xì)
|